Journal article
The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis
Abstract
OBJECTIVE: To evaluate the comparative cardiovascular safety of incretin-based therapies in patients with type 2 diabetes mellitus (T2DM).
METHODS: Medline, Embase, the Cochrane Library and www.clinicaltrials.gov were searched for randomized controlled trials (RCTs) with duration≥12 weeks. Network meta-analysis was performed, followed by subgroup analysis and meta-regression. The Grading of Recommendations Assessment, Development and Evaluation …
Authors
Wu S; Cipriani A; Yang Z; Yang J; Cai T; Xu Y; Quan X; Zhang Y; Chai S; Sun F
Journal
Expert Opinion on Drug Safety, Vol. 17, No. 3, pp. 243–249
Publisher
Taylor & Francis
Publication Date
March 4, 2018
DOI
10.1080/14740338.2018.1424826
ISSN
1474-0338